ClinicalTrials.gg
CompletedNCT07814638Updated Sep 11, 2026

Immediate Protected Weight Bearing Versus Conventional Non-Weight Bearing After Surgical Fixation of Unstable Ankle Fractures

An interventional study of Immediate protected weight bearing and Rehabilitation in Ankle Fractures and Unstabel Ankle Fractures, sponsored by Consorci Sanitari Integral. Completed at 1 site in Spain. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-09-11.

Sponsored by Consorci Sanitari Integral · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 7 months after the study started (first participant enrolled Jan 2023, registered Sep 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
102
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This prospective randomized controlled trial evaluates the safety and effectiveness of immediate protected weight bearing following surgical fixation of unstable ankle fractures. Participants are randomized to immediate protected weight bearing from the first postoperative day using a Walker boot and crutches or conventional non-weight bearing for six weeks. Functional outcome (OMAS), pain (VAS), ankle range of motion, quality of life (SF-12), and postoperative complications are assessed over 12 months.

02

Conditions studied

  • Ankle Fractures
  • Unstabel Ankle Fractures

Browse trials for

Keywords

  • Ankle fracture
  • Immediate protected weight bearing
  • Rehabilitation
  • Walker boot
  • Randomized controlled trial
03

In context

Ankle Fractures

202 studies on the registry are indexed under Ankle Fractures; 44 are open to participants now.

This study's enrollment of 102 is above the median of 90 across 150 interventional studies indexed under Ankle Fractures.

Browse Ankle Fractures studies →

Lead sponsor

Consorci Sanitari Integral is the lead sponsor of 16 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Unstable ankle fracture requiring ORIF.
  • Written .

Exclusion criteria

Exclusion Criteria:

  • Psychiatric disorder.
  • Pre-existing mobility limitation.
  • Cognitive impairment.
  • >30 kg/m².
  • Poorly controlled type 2 diabetes.
  • Soft tissue injury requiring external fixation.
  • Gustilo II/III open fractures.
  • Unstable fixation.
  • Refusal/inability to consent or allow anonymized data use.
  • Any condition compromising safety or validity.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
102 participants (actual)

Study arms

  • Experimental
    Immediate protected weight bearing

    Immediate protected weight bearing from postoperative day 1 using a Walker boot and crutches plus standardized rehabilitation

    Other: Immediate protected weight bearing · Other: Rehabilitation

  • Active comparator
    Conventional treatment

    Conventional non-weight bearing for 6 weeks followed by progressive weight bearing plus standardized rehabilitation

    Other: Rehabilitation

Interventions

  • OtherImmediate protected weight bearing

    Immediate protected weight bearing from postoperative day 1 using a Walker boot and crutches

  • OtherRehabilitation

    Standardised rehabilitation after surgery

06

What researchers measure

Primary outcomes

  1. Olerud-Molander Ankle Score (OMAS).

    Time frame: 6 weeks, 12 weeks, 6 months and 12 months after surgery

Secondary outcomes

  1. Visual Analogic Scale (VAS) for pain

    Time frame: 6 weeks, 12 weeks, 6 months and 12 months.

  2. SF-12 quality of life

    Time frame: 6 weeks, 12 weeks, 6 months and 12 months.

07

Study locations

1 site
  • Hospital Sant Joan Despí Moisès Broggi - Consorci Sanitari Integral
    Sant Joan Despí, Barcelona 08970, Spain
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2023 to primary completion in Jan 2025, 24 months.

Of 69 non-industry interventional studies with no phase under Ankle Fractures, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 61. This study's 24 months is below that.

Counting every sponsor, half of 72 studies reached it within 45 months; a quarter within 23 and three quarters within 61.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 7, 2026
First posted
Sep 11, 2026
StartActual
Jan 15, 2023
Primary completionActual
Jan 15, 2025
CompletionActual
Jan 15, 2026
Last update
Sep 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07814638
Lead sponsor
Consorci Sanitari Integral
Responsible party
Sponsor
First posted
Sep 11, 2026
Start date
Jan 15, 2023
Primary completion
Jan 15, 2025
Completion
Jan 15, 2026
Last update
Sep 11, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion